drugset / Trial / NCT00633438

Effect of Celecoxib Versus Placebo Before and After Knee Surgery on Overall Use of Analgesics After Surgery

NCT00633438

Phase 4 Completed 204 enrolled Viatris Inc.
RandomizedParallel-groupDouble-blindPrevention

Summary

To compare total analgesic use at 24 hours after arthroscopic knee surgery in celecoxib-treated versus placebo-treated patients

Timeline

Start
2004-01
Primary completion
Completion
2004-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Celecoxib Other / unclassified 200 mg Oral

Indications

No indication recorded.